Humacyte (HUMA) CMO Shamik J. Parikh Sells Shares

What Happened Shamik J. Parikh, Chief Medical Officer of Humacyte, reported the sale of 45,887 shares of Humacyte common stock on May 18, 2026. The shares were sold at $0.90 per share for total proceeds of roughly $41,147. This was a sale (a routine sell-to-cover tied to equity vesting), not a purchase.

Key Details

• Transaction date: 2026-05-18; Filing date: 2026-05-20 (filed timely).
• Transaction type/code: Sale (S) — open market/private sale recorded as a sell-to-cover.
• Price and amount: 45,887 shares at $0.90/share; proceeds ≈ $41,147.
• Shares owned after transaction: Not specified in the filing.
• Footnote: The sale was an automated "sell-to-cover" to satisfy statutory tax withholding on vested restricted stock units. It was mandated by the issuer’s practice and entered pursuant to a plan intended to meet the affirmative defense conditions of Rule 10b5-1(c); it therefore does not represent a discretionary sale by the reporting person.

Context Sell-to-cover transactions are common when restricted stock units vest and generally reflect tax-withholding mechanics rather than an executive’s decision to liquidate holdings for investment reasons. This filing is informational and does not, by itself, indicate insider sentiment about company prospects.